A few weeks ago we profiled a call-center-software startup whose name, Exony, stands for ex-Sony, in reference to the herd of employees who left Sony to start the company. Boston’s video game industry is building up an ex-Sony club of its own—Curt Schilling’s Maynard, MA-based 38 Studios. The company announced today that it has hired … Continue reading “Everquest Designer Joins 38 Studios”
Red Bend Downloads $10 Million Update
Today’s mobile phones have so much processing power that they are, in effect, little personal computers—and as with PCs, the software that makes them powerful is continually evolving, even after each handset leaves the factory. So it’s important to have a way of updating both the applications on mobile phones and the “firmware” underlying them … Continue reading “Red Bend Downloads $10 Million Update”
With New Machine, Helicos Brings Personal Genome Sequencing A Step Closer
In the future, your doctor might map your whole genome as a routine diagnostic test. Helicos BioSciences, a five-year-old biotech company in Cambridge, MA, has set out to make that happen in the not-too-distant future—by developing an extremely powerful gene-sequencing technology. The instrument is the size of a refrigerator. A 3,000-pound refrigerator, built on a … Continue reading “With New Machine, Helicos Brings Personal Genome Sequencing A Step Closer”
Aurora, Draper Labs, and BAE Team, IBM’s Merger Machine Steams, Lonelygirl15 Beams, & More Deals News
New England firms had a dismal first quarter in terms of securing venture capital investment, but the past week saw a few of them make stabs at turning around Q2, in much the same way the Sox came back to beat the Rangers. —Stromedix of Cambridge, MA closed a $25 million Series B financing led … Continue reading “Aurora, Draper Labs, and BAE Team, IBM’s Merger Machine Steams, Lonelygirl15 Beams, & More Deals News”
Red Bend Software Obtains $10,000,000 Series E Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cc247fe8-30d7-47b3-b7f1-1cebf8512ce7&Preview=1 Date 4/22/2008 Company Name Red Bend Software Mailing Address 400-1 Totten Pond Road Waltham, MA 02451 Company Description Red Bend Software drives the development, deployment and updating of the world’s most efficient software delivery solutions. Website http://www.redbend.com Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Series E Proceeds Purposes Red … Continue reading “Red Bend Software Obtains $10,000,000 Series E Funding Round”
HealthEdge Software Inc. Receives $13,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6f42c885-9636-4b94-a8ee-66c89e4ff0d1&Preview=1 Date 4/22/2008 Company Name HealthEdge Software Inc. Mailing Address 10 Burlington Mall Road Burlington, MA 01803 Company Description HealthEdge provides health plans, TPAs, PPOs, and insurers of all sizes with unique software applications to position them for success. With patent-pending, next-generation technology, HealthEdge enables payor organizations to pursue innovative, new strategies … Continue reading “HealthEdge Software Inc. Receives $13,000,000 New Round”
Cambria Pharmaceuticals, Inc. Garners $5,400,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3818e85e-0d92-460c-9bbc-bfdacbcf7efa&Preview=1 Date 4/22/2008 Company Name Cambria Pharmaceuticals, Inc. Mailing Address 8A Henshaw St Woburn, MA 01801 Company Description Cambria Pharmaceuticals is focused on the discovery of innovative treatments for serious and progressively disabling neurological disorders. The Company exploits recent discoveries in the genetic basis of these disorders to engineer novel disease models … Continue reading “Cambria Pharmaceuticals, Inc. Garners $5,400,000 Series A Funding”
Resolvyx Pharmaceuticals Secures $25,000,000 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=280bd5fb-b8f3-4336-80e0-f063ce6873c9&Preview=1 Date 4/22/2008 Company Name Resolvyx Pharmaceuticals Mailing Address 6A Preston Court Bedford, MA 01730 Company Description Resolvyx is a biopharmaceutical company committed to the discovery and development of therapies based on the novel concept of inflammation resolution through activation of the body’s own off-switch mechanisms. Website http://www.resolvyx.com/ Transaction Type Venture Equity … Continue reading “Resolvyx Pharmaceuticals Secures $25,000,000 Series B Funding Round”
GlaxoSmithKline plc Acquires Sirtris Pharmaceuticals for $720,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=97c6bb1a-59e5-4a2a-ad8e-4ee0822951e2&Preview=1 Date 4/22/2008 Company Name Sirtris Pharmaceuticals Mailing Address 200 Technology Square Cambridge, MA 02139 Company Description Sirtris Pharmaceuticals” is a biopharmaceutical company developing and commercializing novel therapeutics that modulate sirtuins, a recently discovered family of enzymes that promotes the body’s natural defense against disease. Also known as class III histone deacetylases … Continue reading “GlaxoSmithKline plc Acquires Sirtris Pharmaceuticals for $720,000,000”
OnRequest Images Garners $8,000,000 Series C Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d2f6a044-8f6a-4377-8f6d-23585e005f7b&Preview=1 Date 4/22/2008 Company Name OnRequest Images Mailing Address 1415 Western Avenue Seattle, WA 98101 Company Description OnRequest Images, the world’s leading provider of OnBrand custom imagery, works closely with top corporations to build stronger brands with original, brand-centric photography. OnRequest Images’ technology-driven services have enabled Fortune 1,000 companies to increase brand … Continue reading “OnRequest Images Garners $8,000,000 Series C Round”
New England Venture Investment Falls Sharply in Q1—But Exactly How Far Is the Question
Venture investments in New England firms were down in the first quarter of 2008. Way down. But just how far they tumbled is a matter of debate—as regional numbers from the two leading venture-data sources, just released, differ far more than usual. New England remained in second place nationwide in one study, but fell from … Continue reading “New England Venture Investment Falls Sharply in Q1—But Exactly How Far Is the Question”
IBM Does Due Diligent
IBM is at it again, acquiring another local software company. Privately held Diligent Technologies, a Framingham, MA-based maker of de-duplication software that reduces data storage costs for large enterprises, announced Friday that it’s becoming part of IBM System Storage division of the IBM Systems and Technology Group. The purchase price was not revealed.
With a $25 Million Bankroll and Technology “Fully Baked” by Biogen Idec, Stromedix is Heading into the Uncharted Territory of Fibrosis
Michael Gilman sounds just a touch frazzled when he first picks up the phone. The co-founder of Cambridge, MA’s Stromedix has been chained to his desk for days, attending to all the investors, lawyers, calls, e-mails, paperwork, i-dotting and t-crossing that need to come together to in order for his 2-year-old startup to close its … Continue reading “With a $25 Million Bankroll and Technology “Fully Baked” by Biogen Idec, Stromedix is Heading into the Uncharted Territory of Fibrosis”
Kiva’s Robots Hit Their Stride…er, Slide
Kiva Systems may be winning its battle against the science-fiction robots. The Woburn, MA, company is a newcomer to a hidebound business. It builds “mobile fulfillment systems” that are overturning all the traditions of warehousing by making the shelves move around, rather than the people. The moving is done by squat wheeled robots that maneuver … Continue reading “Kiva’s Robots Hit Their Stride…er, Slide”
HealthPlanOne, LLC Obtains $6,500,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=626b3209-2645-4294-aadd-508c70d394f9&Preview=1 Date 4/21/2008 Company Name HealthPlanOne, LLC Mailing Address 1000 Bridgeport Ave, 4th Floor Shelton, CT 06484 Company Description Healthplanone is a web based health insurance brokerage focused on marketing individual/family health insurance, and small business health insurance. Additionally, we market Medicare Advantage products in select markets. Website http://www.healthplanone.com Transaction Type Venture … Continue reading “HealthPlanOne, LLC Obtains $6,500,000 Series A Funding”
StroMedix Lands $25,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=878417c0-b377-49b0-836e-746a93aab797&Preview=1 Date 4/21/2008 Company Name StroMedix Mailing Address One Canal Park Cambridge, MA 02142 Company Description Stromedix is a clinical-stage biotechnology company committed to developing novel drugs to treat fibrotic organ failure. Stromedix will focus initially on chronic indications but plans to leverage its expertise and expand its therapeutic pipeline into related … Continue reading “StroMedix Lands $25,000,000 Series B Financing Round”
Spark Capital Leads $5 Million Investment in Lonelygirl15 Producers
Boston’s Spark Capital is the lead investor in a $5 million funding round for Eqal (pronounced “equal”), the Los Angeles-based independent studio behind the cult YouTube video series Lonelygirl15. Spark’s Bijan Sabet announced the investment in his personal blog yesterday, and the Wall Street Journal and BusinessWeek have published pieces examining the deal. Eqal was … Continue reading “Spark Capital Leads $5 Million Investment in Lonelygirl15 Producers”
VisEn Medical Sees $5M in Expanded Series B Round
Woburn, MA-based VisEn Medical, which develops fluorescence technology for non-invasive in vivo imaging, today announced it has raised $5 million in an expanded Series B financing round led by Merck Capital Ventures and Flagship Ventures. The initial Series B round, closed last November, took in $7 million.
Google Earth Grows a New Crop of 3-D Buildings, and Other Web Morsels to Savor
One of my goals with this column—which is now in its third week—is to tell you about new stuff on the Web that’s so delicious you just have to taste it. Here are three morsels to tide you over until next time. The first is a quick appetizer: Very Short List, an e-mail newsletter funded … Continue reading “Google Earth Grows a New Crop of 3-D Buildings, and Other Web Morsels to Savor”
Capturing the Personal Essence of Gaming: An Interview with GamerDNA CEO Jon Radoff
It’s a big day for the company formerly known as GuildCafe, which is announcing a new name—GamerDNA—and a new $3 million funding round from Flybridge Capital Partners (see main story). I interviewed GamerDNA founder and CEO (and avid gamer) Jon Radoff about the changes earlier this week; a lightly edited transcript follows. Xconomy: When we … Continue reading “Capturing the Personal Essence of Gaming: An Interview with GamerDNA CEO Jon Radoff”
GamerDNA Rises from GuildCafe, Scavenges $3 Million in Venture Gold
The video gaming and PC gaming industry is big. A whopping $19 billion big in 2007, which doesn’t quite equal revenues from movies ($42 billion) or books ($35 billion), but still accounts for a major chunk of what U.S. consumers spend on media content. So it’s no surprise that there’s a growing list of companies … Continue reading “GamerDNA Rises from GuildCafe, Scavenges $3 Million in Venture Gold”
GM Savors A123Systems and Coskata Deals Amid Dreams of Clean Vehicles That Can’t Crash
When General Motors unveiled its lavish 330-acre, Eero Saarinen-designed technical center in 1956, company president Harlow Curtice cruised to the podium in a shark-finned, bubble-domed Firebird II gas turbine experimental car. “We must put more emphasis on basic research, pure research,” Curtice declared, later adding, “I hope you will come to regard the General Motors … Continue reading “GM Savors A123Systems and Coskata Deals Amid Dreams of Clean Vehicles That Can’t Crash”
GamerDNA Obtains $3,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fa545beb-c628-4558-af41-227e49d87f05&Preview=1 Date 4/18/2008 Company Name GamerDNA Mailing Address 585 Massachusetts Ave, 2nd Floor Cambridge, MA 02139 Company Description GamerDNA is building a community for the millions of people around the world who are passionate about the immersive, engaging experiences that can be found through games. Website http://www.gamerdna.com Transaction Type Venture Equity Transaction … Continue reading “GamerDNA Obtains $3,000,000 Series A Funding Round”
VisEn Medical Lands $5,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=38007cb9-666a-4b1c-9574-73fc3a29f8ca&Preview=1 Date 4/18/2008 Company Name VisEn Medical Mailing Address 12B Cabot Road Woburn, MA 01801 Company Description Founded in 2000 based on technologies developed at the Center for Molecular Imaging Research at the Massachusetts General Hospital, VisEn Medical is developing today’s leading molecular imaging product platforms. Website http://www.visenmedical.com Transaction Type Venture Equity … Continue reading “VisEn Medical Lands $5,000,000 Series B Funding”
Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million
Last year Alnylam Pharmaceuticals (NASDAQ: [[ticker:ALNY]]) of Cambridge, MA, joined forces with Isis Therapeutics (NASDAQ: [[ticker:ISIS]]) in Carlsbad, CA, to form a new affiliate, Regulus Therapeutics. All three companies are doing research on new different types of RNA-based drugs. Today the giant British pharma company GlaxoSmithKline and Regulus announced a new alliance. They will work … Continue reading “Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million”
Biogen Idec Announces Its Own Director Slate—Digs in Against Icahn
Biogen Idec’s battle with Carl Icahn is heating up in advance of the firm’s upcoming annual meeting—for which a date has yet to be announced. The Cambridge, MA-based biotech giant today revealed its slate for the four director seats up for election. They will be contending against three candidates Icahn put forth in January. Biogen … Continue reading “Biogen Idec Announces Its Own Director Slate—Digs in Against Icahn”
Dynogen, Apex Call Off Reverse Merger
Waltham, MA-based Dynogen and Apex Bioventures Acquisition (AMEX: [[ticker:PEX]]) have agreed to call off the $98 million reverse merger they originally announced in February. Citing market conditions, the firms said the terminating the merger agreement was in the best interests of both companies. Dynogen will seek alternative means of financing its programs, which include clinical-stage … Continue reading “Dynogen, Apex Call Off Reverse Merger”
Clean Energy Council Launches Fellowships to Retrain Entrepreneurs for the Cleantech Industry
It’s hard to kick-start a new regional industry if there’s a shortage of entrepreneurs who understand the business. That’s the problem the New England Clean Energy Council (NECEC) is taking on with a new fellowship program designed to retrain entrepreneurs experienced in the software business and other industries so that they can venture into cleantech. … Continue reading “Clean Energy Council Launches Fellowships to Retrain Entrepreneurs for the Cleantech Industry”
Radius Health is Betting on a Better Treatment for Osteoporosis
Radius Health, a biotech company in Cambridge, MA, has a lot hanging on its clinical trial of a new treatment for osteoporosis. Two weeks ago all the patients were enrolled in the study of the drug, which actually helps bones grow stronger again, rather than just slowing down their decay. As Xconomy has reported, passing … Continue reading “Radius Health is Betting on a Better Treatment for Osteoporosis”
OwnerIQ Capitalizes on Intelligence about Users
I’m one of those people who makes special folders in my filing cabinet for the owner’s manuals that come with every new gadget or appliance I buy. If you want to see the manual for my radioactive-green Nokia 6130 cell phone, I can probably dig it up. (Never mind that I haven’t used that phone … Continue reading “OwnerIQ Capitalizes on Intelligence about Users”
Microsoft Corporation Acquires Farecast for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2bfa61e9-2a97-46b1-aabb-c12b7defe8ca&Preview=1 Date 4/17/2008 Company Name Farecast Mailing Address 200 West Thomas Street Seattle, WA 98119 Company Description Farecast.com is the first airfare prediction website. We help online travel shoppers save money by answering the question; should you buy now or wait? In our beta version, we now offer airfare predictions from over … Continue reading “Microsoft Corporation Acquires Farecast for Undisclosed Sum”
Kalido Expands to Bangalore
Kalido, the Burlington, MA-based data warehouse customization company we profiled in March, said yesterday that it’s opening a product development and servies office in Bangalore, India. The office will complement rather than replace Kalido’s existing operations in Massachusetts and London, the company says. “We’ve doubled our product portfolio in the last year and demand for … Continue reading “Kalido Expands to Bangalore”
$50 Million Serono Expansion to Create 100 New Massachusetts Jobs
The pharmaceutical company EMD Serono today announced that it is investing $50 million in building a new research center in Billerica, MA. Construction will begin early next year. When the center is ready in 2010 it will house 200 scientists doing research in cancer and fertility as well as in medicinal chemistry and protein engineering. … Continue reading “$50 Million Serono Expansion to Create 100 New Massachusetts Jobs”
Hydroid Dives into Navy Contract
The Naval Oceanogaphic Office, the wing of the Defense Department responsible for charting the ocean bottom, has signed a five-year support contract with Hydroid, the Pocasset, MA-based maker of robot submarines. Okay, they’re actually called AUVs, or autonomous underwater vehicles—not to be confused with UAVs, for unmanned aerial vehicles (though we wrote about those earlier … Continue reading “Hydroid Dives into Navy Contract”
Tapping TV Signals: Charles River Adds to Investment in Rosum
The Global Positioning System helps millions find their way around the surface of the planet every day. But if you’ve ever walked around with a handheld GPS unit, you know that the radio signals transmitted by GPS satellites are so weak that they’re hard to pick up under tree cover, let alone in dense urban … Continue reading “Tapping TV Signals: Charles River Adds to Investment in Rosum”
A Lawsuit for Biogen, A Suitor for Millennium, The Suits Who Made Their Own Fate, & More Life Sciences News
First Carl Icahn stirred the Biogen Idec pot again, to nobody’s surprise, then Takeda swept one of the area’s mainstay companies off its feet—to everybody’s surprise. It’s been an exciting week for Boston-area biotech. —Icahn rang the bell on yet another round in his battle to force a sale of Biogen Idec (NASDAQ: [[ticker:BIIB]]) by … Continue reading “A Lawsuit for Biogen, A Suitor for Millennium, The Suits Who Made Their Own Fate, & More Life Sciences News”
BSX Snares CryoCor for $17.6 Million
Boston Scientific will acquire San Diego-based CryoCor, with which it has an existing agreement to develop treatments for cardiac arrhythmia, for approximately $17.6 million, the company announced today. Under the cash deal, Natick, MA-based Boston Scientific (NYSE: [[ticker:BSX]]) will pay $1.35 per share for CryoCor (NASDAQ: [[ticker:CRYO]]), which represents a roughly 20 percent premium over … Continue reading “BSX Snares CryoCor for $17.6 Million”
Codon Devices to Engineer Protein Drug for Merrimack Pharmaceuticals
Two local biotech companies have joined forces to develop a new protein drug. The agreement, between Codon Devices and Merrimack Pharmaceuticals, both of Cambridge, MA, was made public today. Merrimack focuses on cancer and autoimmune disease. It has one drug already in clinical trials for treatment of rheumatoid arthritis, psoriasis, and the eye disease uveitis. … Continue reading “Codon Devices to Engineer Protein Drug for Merrimack Pharmaceuticals”
Paratek Pharmaceuticals Garners $18,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=01956eee-ef43-4c5d-bcef-45781f022750&Preview=1 Date 4/16/2008 Company Name Paratek Pharmaceuticals Mailing Address 75 Kneeland Street Boston, MA 02111 Company Description Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases. Website http://www.paratekpharm.com … Continue reading “Paratek Pharmaceuticals Garners $18,000,000 New Financing”
Aileron Raises $10 Million
Cambridge-based biopharmaceutical company Aileron Therapeutics, which is developing peptide drugs for the treatment of cancer and other diseases, has raised $10 million in a private placement of preferred stock, the company announced today. Apple Tree Partners and the Novartis Venture Fund led the round.
ArQule Gets a New CEO
Woburn, MA-based ArQule, which is developing several compounds known as kinase inhibitors as potential cancer therapies, said today that Paolo Pucci, a Bayer senior vice president overseeing Bayer-Schering’s global oncology and therapeutics business, will take over as the company’s new CEO. Pucci succeeds Stephen Hill, a nine-year veteran of the company who announced his approaching … Continue reading “ArQule Gets a New CEO”
Entrepreneurs at Three Massachusetts Colleges Rake in the Prize Money
While the rest of us have spent the last few days getting ready to turn our money over to state and federal governments, several area colleges have been giving theirs to student entrepreneurs. First up was Harvard, which last Wednesday awarded more than $50,000 in prizes to the winners of the I³ Harvard College Innovation … Continue reading “Entrepreneurs at Three Massachusetts Colleges Rake in the Prize Money”
QD Vision Collects $9M in Third Round
PE Week Wire is reporting, based on a regulatory filing, that Watertown, MA-based QD Vision, which is building brighter, more efficient displays based on “quantum dot” technology, has collected $9 million of a $16 million Series C funding round. Existing backers Highland Capital Partners and North Bridge Venture Partners are leading the investment. As we … Continue reading “QD Vision Collects $9M in Third Round”
MIT Sloan Sales Conference
“The science and strategies of champion rainmakers.” That’s the title of the 2008 MIT Sloan Sales Conference, which brings together top industry experts, leading academics, and business students for a day of learning, networking, and rainmaking. Bob will be moderating the morning’s Sales Automation and Management panel.
The Funded Opens Individual VC Ratings to Public View
Gossip and the inside dope are hard to resist—especially when they pertain to people who might hold your company’s fate in the palm of their hands. So, when you think about it, it was only a matter of time before the controversial website TheFunded opened up its venture capitalist ratings to more widespread view. The … Continue reading “The Funded Opens Individual VC Ratings to Public View”
IBM and the Art of Acquisitions
“If you do something 60 times you are going to develop some best practices,” Scott Hebner says. This could be said of many things. The thing Hebner is talking about is acquisitions—software company acquisitions by his employer, IBM, to be exact. Hebner is vice president of marketing and strategy for IBM Rational Software, which makes … Continue reading “IBM and the Art of Acquisitions”
Aileron Therapeutics, Inc. Receives $10,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7f91286a-bc43-4b8f-a265-b2ee079ed43c&Preview=1 Date 4/15/2008 Company Name Aileron Therapeutics, Inc. Mailing Address 840 Memorial Drive Cambridge, MA 02139 Company Description Aileron Therapeutics is an emerging biopharmaceutical company that is applying its proprietary cell permeable peptide technology to generate breakthrough therapeutics for the treatment of cancer and other diseases. Aileron’s technology is the first and … Continue reading “Aileron Therapeutics, Inc. Receives $10,000,000 New Funding Round”
Pathway Medical Technologies Secures $24,500,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3b01269b-1315-4882-a7a2-2ecbf941373d&Preview=1 Date 4/15/2008 Company Name Pathway Medical Technologies Mailing Address 10801 120th Ave NE Kirkland, WA 98033 Company Description Pathway Medical Technologies, Inc. (Pathway), located in Redmond, Washington was founded in 1998 to design, develop and manufacture innovative medical devices intended for the treatment of arterial disease. The company’s initial focus is … Continue reading “Pathway Medical Technologies Secures $24,500,000 New Funding”
BuddyTV Obtains $6,500,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f56e93a6-0d2e-4e02-8b29-31aeca199e66&Preview=1 Date 4/15/2008 Company Name BuddyTV Mailing Address 100 West Harrison Street Seattle, WA 98119 Company Description Our goal is to bring entertainment and content closer to fans. We do this by providing original articles, news, spoilers, and interviews on an extremely broad range of television content. We also provide a forum … Continue reading “BuddyTV Obtains $6,500,000 Series B Funding”
Aurora, Draper, BAE Win Contract to Build Long-Duration Surveillance Aircraft
Talk about a long flight. While the world’s longest passenger jet trip (the 18-hour, 40-minute journey from Newark to Singapore) may be a killer, the Defense Advanced Research Projects Agency has hired a group of organizations with Massachusetts operations, including Aurora Flight Sciences, Draper Laboratories, and BAE Systems, to build a plane that can stay … Continue reading “Aurora, Draper, BAE Win Contract to Build Long-Duration Surveillance Aircraft”